Diana Stefani-Hunyady

Seminars

Wednesday 19th November 2025
Advancing Precision Repigmentation Through Real-World Learnings in Vitiligo
9:00 am
  • Key outcomes and safety insights from adult and adolescent trials investigating topical JAK inhibition in vitiligo
  • Translating clinical success to pediatric populations and adapting protocols for less extensive disease
  • Navigating operational and regulatory challenges including enrollment barriers and long-term data expectations
  • Applying lessons from atopic dermatitis programs to improve trial design, endpoint strategy, and FDA alignment in vitiligo
Wednesday 19th November 2025
Advancing Precision Repigmentation Through Real-World Learnings in Vitiligo
9:00 am
  • Key outcomes and safety insights from adult and adolescent trials investigating topical JAK inhibition in Vitiligo
  • Translating clinical success to pediatric populations and adapting protocols for less extensive disease
  • Navigating operational and regulatory challenges including enrollment barriers and long-term data expectations
  • Applying lessons from Atopic Dermatitis programs to improve trial design, endpoint strategy, and FDA alignment in Vitiligo